States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand

US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.

More from Legislation

More from Pink Sheet